ATE485055T1 - Adjuvierte antigene meningokokkenzusammensetzungen - Google Patents
Adjuvierte antigene meningokokkenzusammensetzungenInfo
- Publication number
- ATE485055T1 ATE485055T1 AT02788442T AT02788442T ATE485055T1 AT E485055 T1 ATE485055 T1 AT E485055T1 AT 02788442 T AT02788442 T AT 02788442T AT 02788442 T AT02788442 T AT 02788442T AT E485055 T1 ATE485055 T1 AT E485055T1
- Authority
- AT
- Austria
- Prior art keywords
- adjuved
- antigen
- meningococcal
- compositions
- meningococcal compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0129007.1A GB0129007D0 (en) | 2001-12-04 | 2001-12-04 | Adjuvanted antigenic meningococcal compositions |
| PCT/IB2002/005662 WO2003047619A2 (en) | 2001-12-04 | 2002-12-04 | Adjuvanted antigenic meningococcal compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE485055T1 true ATE485055T1 (de) | 2010-11-15 |
Family
ID=9926977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02788442T ATE485055T1 (de) | 2001-12-04 | 2002-12-04 | Adjuvierte antigene meningokokkenzusammensetzungen |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20060008476A1 (de) |
| EP (1) | EP1448230B1 (de) |
| JP (2) | JP4414226B2 (de) |
| AP (1) | AP2004003074A0 (de) |
| AT (1) | ATE485055T1 (de) |
| AU (1) | AU2002353417A1 (de) |
| CA (1) | CA2468935C (de) |
| CY (1) | CY1111114T1 (de) |
| DE (1) | DE60238075D1 (de) |
| GB (1) | GB0129007D0 (de) |
| WO (1) | WO2003047619A2 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9513371D0 (en) * | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
| ES2391153T3 (es) * | 2000-02-28 | 2012-11-22 | Novartis Vaccines And Diagnostics S.R.L. | Expresión heteróloga de proteínas de Neisseria |
| JP2004535187A (ja) * | 2001-06-07 | 2004-11-25 | ワイス・ホールデイングス・コーポレーシヨン | アジュバントとしてのコレラホロトキシンの突然変異形 |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| EP1506007B1 (de) * | 2002-05-14 | 2011-06-22 | Novartis Vaccines and Diagnostics S.r.l. | Kombinationsimpfstoff gegen bakterielle meningitis, der über die schleimhaut appliziert wird |
| GB0302218D0 (en) | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
| GB0227346D0 (en) * | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| PL1961426T3 (pl) | 2003-10-02 | 2012-03-30 | Gsk Vaccines S R L | Skojarzone szczepionki przeciwko zapaleniu opon mózgowo-rdzeniowych |
| CA2756522C (en) | 2009-03-24 | 2018-06-26 | Novartis Ag | Adjuvanting meningococcal factor h binding protein |
| EP3246044B2 (de) | 2010-08-23 | 2024-04-10 | Wyeth LLC | Stabile formulierungen von neisseria-meningitidis-rlp2086-antigenen |
| ES2864635T3 (es) | 2010-09-10 | 2021-10-14 | Wyeth Llc | Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis |
| WO2012059592A1 (en) * | 2010-11-05 | 2012-05-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compounds for delivering a therapeutic or imaging agent to the brain |
| GB201102090D0 (en) * | 2011-02-08 | 2011-03-23 | Univ Sheffield | Antigenic polypeptide |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| MY167723A (en) | 2012-03-09 | 2018-09-21 | Pfizer | Neisseria meningitidis compositions and methods thereof |
| JP2015524418A (ja) | 2012-07-27 | 2015-08-24 | アンスティテュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 血管内皮細胞への髄膜炎菌の線毛媒介接着の受容体としてのｃｄ１４７ |
| ES2685894T3 (es) | 2013-03-08 | 2018-10-15 | Pfizer Inc. | Polipéptidos de fusión inmunogénicos |
| WO2015033251A2 (en) | 2013-09-08 | 2015-03-12 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| KR20190049940A (ko) | 2015-02-19 | 2019-05-09 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
| AU2018215585B2 (en) | 2017-01-31 | 2022-03-17 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| BR112021012250A2 (pt) * | 2018-12-21 | 2021-09-08 | Griffith University | Composições, métodos e usos para induzir uma resposta imune |
| WO2021067628A2 (en) * | 2019-10-01 | 2021-04-08 | Beth Israel Deaconess Medical Center, Inc. | Conformation-specific antibodies that bind nuclear factor kappa-light-chain-enhancer of activated b cells |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5153312A (en) * | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| CA2308606A1 (en) * | 1997-11-06 | 1999-05-20 | Chiron S.P.A. | Neisserial antigens |
| GB9726398D0 (en) * | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
| DE69941567D1 (de) * | 1998-01-14 | 2009-12-03 | Novartis Vaccines & Diagnostic | Antigene aus neisseria meningitidis |
| AU770333B2 (en) * | 1998-09-30 | 2004-02-19 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Mutant cholera holotoxin as an adjuvant |
| US7384640B1 (en) * | 1999-09-30 | 2008-06-10 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant |
| AR045702A1 (es) * | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
-
2001
- 2001-12-04 GB GBGB0129007.1A patent/GB0129007D0/en not_active Ceased
-
2002
- 2002-12-04 JP JP2003548874A patent/JP4414226B2/ja not_active Expired - Fee Related
- 2002-12-04 DE DE60238075T patent/DE60238075D1/de not_active Expired - Lifetime
- 2002-12-04 AP APAP/P/2004/003074A patent/AP2004003074A0/en unknown
- 2002-12-04 US US10/497,709 patent/US20060008476A1/en not_active Abandoned
- 2002-12-04 EP EP02788442A patent/EP1448230B1/de not_active Expired - Lifetime
- 2002-12-04 AU AU2002353417A patent/AU2002353417A1/en not_active Abandoned
- 2002-12-04 CA CA2468935A patent/CA2468935C/en not_active Expired - Fee Related
- 2002-12-04 WO PCT/IB2002/005662 patent/WO2003047619A2/en active Application Filing
- 2002-12-04 AT AT02788442T patent/ATE485055T1/de not_active IP Right Cessation
-
2009
- 2009-04-10 JP JP2009096521A patent/JP2009155344A/ja not_active Withdrawn
-
2010
- 2010-05-25 US US12/787,366 patent/US20100233205A1/en not_active Abandoned
-
2011
- 2011-01-18 CY CY20111100056T patent/CY1111114T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009155344A (ja) | 2009-07-16 |
| US20100233205A1 (en) | 2010-09-16 |
| WO2003047619A3 (en) | 2003-10-23 |
| JP2005511662A (ja) | 2005-04-28 |
| WO2003047619A2 (en) | 2003-06-12 |
| GB0129007D0 (en) | 2002-01-23 |
| AP2004003074A0 (en) | 2004-06-30 |
| US20060008476A1 (en) | 2006-01-12 |
| CY1111114T1 (el) | 2015-06-11 |
| CA2468935A1 (en) | 2003-06-12 |
| DE60238075D1 (de) | 2010-12-02 |
| EP1448230B1 (de) | 2010-10-20 |
| AU2002353417A1 (en) | 2003-06-17 |
| EP1448230A2 (de) | 2004-08-25 |
| JP4414226B2 (ja) | 2010-02-10 |
| CA2468935C (en) | 2013-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE485055T1 (de) | Adjuvierte antigene meningokokkenzusammensetzungen | |
| NO20034410L (no) | Vaksinesammensetning | |
| FI20010780A0 (fi) | Parannetut koostumukset | |
| NO20026175L (no) | Vaksinesammensetning | |
| ATE303787T1 (de) | Schergelzusammensetzungen | |
| IS6915A (is) | Lyfjablanda | |
| IS7297A (is) | Streptococcis Pneumoniae bóluefni | |
| AR028197A1 (es) | Composiciones antitranspirantes | |
| DK1427444T3 (da) | West-nil-vaccine | |
| BR0210619A (pt) | composição | |
| NO20033882D0 (no) | Vaksine | |
| IS7081A (is) | Lyfjablanda | |
| DE60224595D1 (de) | Fluoroelastomere | |
| ATE369830T1 (de) | Schweisshemmende zusammensetzungen | |
| ATE314049T1 (de) | Schweisshemmende zusammensetzungen | |
| GB0126378D0 (en) | Antigen | |
| EE200300569A (et) | CD44v6-spetsiifilised antikehad | |
| DE60229463D1 (de) | Fluoroelastomere | |
| EE200300480A (et) | Pregabaliini-laktoosi konjugaadid | |
| DE50202942D1 (de) | Basenhältige mikronährstoffmischung | |
| DE50206933D1 (de) | Zweimassenschwungrad | |
| DE60213119D1 (de) | Zweimassenschwungrad | |
| ITTO20020744A0 (it) | Composizione | |
| DE50100362D1 (de) | Kreuzscheibenkupplung | |
| ITTO20020745A0 (it) | Composizione |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |